Stifel Nicolaus Downgrades Allergan To Hold

Analysts at Stifel Nicolaus downgraded Allergan

from Buy to Hold and removed the price target of $200.00. Allergan shares have gained 107.99% over the past 52 weeks, while the S&P 500 index has surged 12.08% in the same period. Allergan's shares closed at $208.47 in pre-market trading.